Investing in Stocks Made Easy!
at ₹0 Brokerage with 5paisa.
+91
By proceeding, you agree to all T&C*
Investing in Stocks Made Easy!
We've sent a 6-digit verification code to +91 99123918232
Didn't receive the code? Resend
LYKALABS

Lyka Labs Share Price

 

 

Lyka Labs live price: ₹61.41. It opened at ₹62 vs previous close ₹61; intraday high/low: ₹62/₹60. The 50 & 200 DMA stand at ₹60.49/₹77.11.

Lyka Labs Performance

  • Today's Low
  • ₹60
  • Today's High
  • ₹62
  • 52 Week Low
  • ₹44
  • 52 Week High
  • ₹129
  • Open Price₹62
  • Previous Close₹61
  • Volume8,672
  • 50 DMA₹60.49
  • 100 DMA₹65.45
  • 200 DMA₹77.11

Lyka Labs Chart

Investment Returns

  • Over 1 Month + 3.72%
  • Over 3 Month -1.32%
  • Over 6 Month -27.22%
  • Over 1 Year -47.48%

Smart Investing Starts Here Start SIP with Lyka Labs for Steady Growth!

Invest Now

Lyka Labs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -335.4
  • PEG Ratio
  • 2.9
  • Market Cap Cr
  • 219
  • P/B Ratio
  • 2.2
  • Average True Range
  • 3.06
  • EPS
  • 0
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.93
  • RSI
  • 53.84
  • MFI
  • 66.43

Latest Stock News Updates

Lykka Labs shares rally 7% on CDSCO nod for diabetic neuropathy pain drug

Lyka Labs shares rose as the company announced that it has received the CDSCO approval for manufacturing & marketing of of Pregabalin Gel 8% w/w for use in patients with Diabetic Neuropathic Pain.

Lyka Labs Standalone December 2023 Net Sales at Rs 31.42 crore, up 83.37% Y-o-Y

Lyka Labs Consolidated September 2023 Net Sales at Rs 27.99 crore, up 9.64% Y-o-Y

Lyka Labs Financials

Lyka Labs Technicals

EMA & SMA

Current Price
₹61.41
+ 0.14 (0.23%)
pointer
  • Bearish Moving Average 5
  • Bullish Moving Average 11
  • 20 Day
  • ₹60.44
  • 50 Day
  • ₹60.49
  • 100 Day
  • ₹65.45
  • 200 Day
  • ₹77.11

Resistance and Support

61.32 Pivot Speed
  • R3 64.80
  • R2 63.61
  • R1 62.51
  • S1 60.22
  • S2 59.03
  • S3 57.93

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Lyka Labs has an operating revenue of Rs. 133.84 Cr. on a trailing 12-month basis. An annual revenue growth of 25% is outstanding, Pre-tax margin of 8% is okay, ROE of 7% is fair but needs improvement. The company has a reasonable debt to equity of 18%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and around 7% up from its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 5 which is a POOR score indicating inconsistency in earnings, a RS Rating of 13 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C which is evident from recent supply seen, Group Rank of 51 indicates it belongs to a fair industry group of Medical-Generic Drugs and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Lyka Labs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-25 Audited Results
2026-03-31 Others To consider other business matters. to conisder 1. To Approve Redemption of unlisted 1,08,570 10% Cumulative Redeemable Preference Shares of Rs.100/- each. 2. Other business matters.
2026-01-29 Quarterly Results
2025-11-12 Quarterly Results & Others To consider other business matters. to conisder 1. To Approve Redemption of unlisted 1,08,570 10% Cumulative Redeemable Preference Shares of Rs.100/- each. 2. Other business matters.
2025-09-29 Others Rs.0.00 to conisder 1. To Approve Redemption of unlisted 1,08,570 10% Cumulative Redeemable Preference Shares of Rs.100/- each. 2. Other business matters.

Lyka Labs Shareholding Pattern

58.16%
0.01%
0.28%
0.29%
0%
31.06%
10.2%

Lyka Labs FAQs

Lyka Labs share price is ₹61 As on 24 May, 2026 | 09:11

The Market Cap of Lyka Labs is ₹219.2 Cr As on 24 May, 2026 | 09:11

The P/E ratio of Lyka Labs is -335.4 As on 24 May, 2026 | 09:11

The PB ratio of Lyka Labs is 2.2 As on 24 May, 2026 | 09:11

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23